Goldman Sachs Group »

Diamedica Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $531k 77k 6.87
2025-03-31 $462k 122k 3.79
2024-12-31 $374k 69k 5.43
2019-06-30 $253k 51k 4.95